Home/NETRIS Pharma/Patrick Mehlen

PM

Patrick Mehlen

Scientific Founder/Key Opinion Leader

Therapeutic Areas

NETRIS Pharma Pipeline

Drug	Indication	Phase
NP137	Solid Tumors (e.g., Endometrial, Pancreatic Cancer)	Phase 2

Leadership Team at NETRIS Pharma

Prof./Presenter (likely Clinical or Scientific Lead)

View full NETRIS Pharma profile